4.6 Article

Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements

Related references

Note: Only part of the references are listed.
Review Immunology

GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives

Nathalie Garcon et al.

EXPERT REVIEW OF VACCINES (2007)

Article Immunology

The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

Karen Smith Korsholm et al.

IMMUNOLOGY (2007)

Article Multidisciplinary Sciences

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Danila Valmori et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Multidisciplinary Sciences

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

Amanda L. Gavin et al.

SCIENCE (2006)

Article Chemistry, Multidisciplinary

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency

J Kazzaz et al.

JOURNAL OF CONTROLLED RELEASE (2006)

Article Immunology

Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system

I Rosenkrands et al.

INFECTION AND IMMUNITY (2005)

Article Immunology

FcγRIV:: A novel FcR with distinct IgG subclass specificity

F Nimmerjahn et al.

IMMUNITY (2005)

Review Immunology

Immunotherapeutic uses of CpG oligodeoxynucleotides

DM Klinman

NATURE REVIEWS IMMUNOLOGY (2004)

Review Biotechnology & Applied Microbiology

Influenza virosomes as an efficient system for adjuvanted vaccine delivery

R Glück et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2004)

Article Immunology

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

L Brandt et al.

INFECTION AND IMMUNITY (2000)